Exchanges
BSE, NSE
Industry
Pharmaceuticals
Issue
Book building

Akums Drugs & Pharmaceuticals IPO

₹796.25

+17.27% on listing

Listing-day close · NSE · 6 Aug 2024 · issue price ₹679

Akums Drugs & Pharmaceuticals’ ₹1,857 crore IPO was priced at ₹679 a share. It listed on the NSE on 6 Aug 2024 and closed its first day at ₹796.25, up 17.27% on the issue price.

Timeline

  1. Opens
  2. Closes
  3. Allotment
  4. Refunds
  5. Shares in demat
  6. Listing

Issue details

Issue size
₹1,857 Cr
Fresh issue
₹681 Cr
Offer for sale
₹1,176 Cr
Lot size
22 shares
Minimum investment
₹14,938
Face value
₹2
Registrar
MUFG Intime India

Subscription

Akums Drugs & Pharmaceuticals IPO subscription by investor category
CategoryShares offeredTimes subscribed
Total—35.54×

Overall, from the basis of allotment.

Financials and valuation

EPS (post-issue)
₹0.05
Price to book
13.7
ROE
0.11%
ROCE
3.37%
Debt to equity
0.69
EBITDA margin
3.73%
PAT margin
0.02%
Promoter holding
82.48% → 75.29%

Financials as of 31 Mar 2024, from the offer documents.

Listing

Listing date
6 Aug 2024
Issue price
₹679
Open
₹725.00
High
₹797.50
Low
₹725.00
Close
₹796.25

Listing day on the NSE. The close was +17.27% on the issue price.

AKUMS DRUGS AND PHARMA L share price today

FAQs

When did the Akums Drugs & Pharmaceuticals IPO open and close?

It opened on 30 Jul 2024 and closed on 1 Aug 2024.

What was the Akums Drugs & Pharmaceuticals IPO price?

The price band was ₹646–679 a share. The final issue price was ₹679.

What is the lot size and minimum investment?

One lot is 22 shares, ₹14,938 at ₹679 a share. Retail investors apply in whole lots.

How much did Akums Drugs & Pharmaceuticals raise?

₹1,857 crore: ₹681 crore of new shares and ₹1,176 crore offered by existing shareholders.

How many times was the Akums Drugs & Pharmaceuticals IPO subscribed?

35.54 times overall.

How did Akums Drugs & Pharmaceuticals list?

It listed on the NSE on 6 Aug 2024 at ₹725.00 and closed the day at ₹796.25, up 17.27% on the ₹679 issue price.

Who is the registrar of the Akums Drugs & Pharmaceuticals IPO?

MUFG Intime India handles the allotment, refunds and credit of shares.

For information only. Not investment advice or a research report.

Full disclaimer

See how an IPO fits your plan

Armor checks every holding against your goals, risk and timeline.

Get the app